Thomas Moritz
Impact in
- Immunology top 5%
- Immune cells in cancer
- Phagocytosis and Immune Regulation
- Hematology top 5%
Papers in
-
- CRISPR and Genetic Engineering 20
- Pluripotent Stem Cells Research 14
- RNA Interference and Gene Delivery 11
- Renal and related cancers 11
- Genetics 21
- Virus-based gene therapy research 17
- Chronic Lymphocytic Leukemia Research 9
- Co-authors
- Nico Lachmann (37 shared papers)Axel Schambach (26 shared papers)Mania Ackermann (17 shared papers)J. Vollmann (1 shared paper)Sabine Baumgartner (1 shared paper)Helmut Wagentristl (1 shared paper)Tobias Cantz (7 shared papers)W. Widdra (6 shared papers)
- Journals
- Gene Therapy (7 papers)Alcoholism Clinical and Experimental Research (3 papers)European Journal Of Haematology (3 papers)Metabolism (3 papers)Cancer Immunology Immunotherapy (3 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Thomas Moritz
86 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 122
- Immunology 649
- Hematology 257
- Biochemistry 159
- Genetics 217
- Molecular Biology 1.1k
Countries citing papers authored by Thomas Moritz
This map shows the geographic impact of Thomas Moritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Moritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Moritz more than expected).
Fields of papers citing papers by Thomas Moritz
This network shows the impact of papers produced by Thomas Moritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Moritz. The network helps show where Thomas Moritz may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Moritz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 235 | |
| 2 | 2007 | 191 | |
| 3 | 2015 | 145 | |
| 4 | 1995 | 122 | |
| 5 | 2018 | 111 | |
| 6 | 1989 | 90 | |
| 7 | 2014 | 90 | |
| 8 | 1997 | 83 | |
| 9 | 2008 | 80 | |
| 10 | 2020 | 78 | |
| 11 | 2011 | 73 | |
| 12 | 2016 | 68 | |
| 13 | 2015 | 66 | |
| 14 | 2013 | 66 | |
| 15 | 2015 | 57 | |
| 16 | 1995 | 55 | |
| 17 | 1991 | 54 | |
| 18 | 2018 | 53 | |
| 19 | 1992 | 53 | |
| 20 | 1993 | 51 |
About Thomas Moritz
Thomas Moritz is a scholar working on Molecular Biology, Genetics, Oncology, Immunology and Hematology, having authored 90 papers that have together received 2.8k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (20 papers), Virus-based gene therapy research (17 papers), Pluripotent Stem Cells Research (14 papers), RNA Interference and Gene Delivery (11 papers), Renal and related cancers (11 papers), Chronic Lymphocytic Leukemia Research (9 papers), CAR-T cell therapy research (9 papers) and Chronic Myeloid Leukemia Treatments (9 papers). The work is most often cited by research in Immunology (649 citations), Hematology (257 citations), Biochemistry (159 citations), Genetics (217 citations) and Molecular Biology (1.1k citations). Thomas Moritz has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Nico Lachmann, Axel Schambach, Mania Ackermann, J. Vollmann, Sabine Baumgartner, Helmut Wagentristl, Tobias Cantz, W. Widdra, Nils Pfaff and N. Niederle. Their work appears in journals such as Gene Therapy, Alcoholism Clinical and Experimental Research, European Journal Of Haematology, Metabolism and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.